Meta-Analysis of the Relationship between cagA Seropositivity and Gastric Cancer

Gastroenterology

Volumn 125, Issue 6, 2003, Pages 1636-1644

  Huang, Jia Qing ^a,c   Zheng, Ge Fan ^b   Sumanac, Katica ^a   Irvine, E Jan ^a   Hunt, Richard H ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b QUEEN MARY HOSPITAL   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; DNA;

ARTICLE; BACTERIAL STRAIN; CANCER RISK; CARDIA; CASE CONTROL STUDY; DISEASE ASSOCIATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CANCER;

EID: 0344197110     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2003.08.033     Document Type: Article

References (45)

1. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-6740.
2. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori IARC monographs on the evaluation of carcinogenic risks to humans. Volume 61. Lyon, France: IARC, 1994.
3. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169-1179.
4. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-353.
5. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.
6. Enroth H, Kraaz W, Engstrand L, Nyren O, Rohan T. Helicobacter pylori strain types and risk of gastric cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 2000;9:981-985.
7. Rudi J, Kolb C, Maiwald M, Zuna I, von Herbay A, Galle PR, Stremmel W. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci 1997;42:1652-1659.
8. Yamaoka Y, Kodama T, Kashima K, Graham DY. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer. J Clin Pathol 1999;52:215-218.
9. Kikuchi S, Crabtree JE, Forman D, Kurosawa M. Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults. Am J Gastroenterol 1999;94:3455-3459.
10. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997;40:297-301.
11. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-2211.
12. Brenner H, Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer 2000;88:274-279.
13. Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, Perez-Perez GI, Schoenberg JB, Stanford JL, Rotterdam H, West AB, Fraumeni JF Jr. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588-590.
14. Limburg P, Qiao Y, Mark S, Wang G, Perez-Perez G, Blaser M, Wu Y, Zou X, Dong Z, Taylor P, Dawsey S. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer Inst 2001;93:226-233.
15. Queiroz DM, Mendes EN, Rocha GA, Oliveira AM, Oliveira CA, Magalhaes PP, Moura SB, Cabral MM, Nogueira AM. cagA-positive Helicobacter pylori and risk for developing gastric carcinoma in Brazil. Int J Cancer 1998;78:135-139.
16. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Munakata A, Crabtree JE. CagA seropositivity associated with development of gastric cancer in a Japanese population. Clin Pathol 1998;51:225-228.
17. Ekström AM, Held M, Hansson L, Engstrand L, Nyrén O. Helicobacter pylori in gastric cancer estimated by cagA immunoblot as a marker of past infection. Gastroenterology 2001;121:784-791.
18. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2012.
19. Lichtenstein MY, Mulrow CD, Elwood PC. Guidelines for reading case-control studies. J Chron Dis 1987;40:893-903.
20. Colditz GA, Burdick E, Mosteller F. Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. Am J Epidemiol 1995;142:371-382.
21. Berlin JA. Invited commentary: benefits of heterogeneity in metaanalysis of data from epidemiologic studies. Am J Epidemiol 1995;142:383-387.
22. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997;315:629-634.
23. Maeda S, Yoshida H, Ogura K, Yamaji Y, Ikenoue T, Mitsushima T, Tagawa H, Kawaguchi R, Mori K, Mafune Ki, Kawabe T, Shiratori Y, Omata M. Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs. Cancer 2000;88:1530-1535.
24. Rugge M, Busatto G, Cassaro M, Shiao YH, Russo V, Leandro G, Avellini C, Fabiano A, Sidoni A, Covacci A. Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype. Cancer 1999;85:2506-2511.
25. Matsukura N, Onda M, Kato S, Hasegawa H, Okawa K, Shirakawa T, Tokunaga A, Yamashita K, Hayashi A. Cytotoxin genes of Helicobacter pylori in chronic gastritis, gastroduodenal ulcer and gastric cancer: an age and gender matched case-control study. Jpn J Cancer Res 1997;88:532-536.
26. de Figueiredo Soares T, de Magalhaes Queiroz DM, Mendes EN, Rocha GA, Rocha Oliveira AM, Alvares Cabral MM, de Oliveira CA. The interrelationship between Helicobacter pylori vacuolating cytotoxin and gastric carcinoma. Am J Gastroenterol 1998;93:1841-1847.
27. Konturek SJ, Starzynska T, Konturek PC, Karczewska E, Marlicz K, Lawniczak M, Jaroszewicz-Heigelman H, Bielanski W, Hartwich A, Ziemniak A, Hahn EG. Helicobacter pylori and cagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer. Scand J Gastroenterol 2002;37:891-898.
28. Nomura AM, Lee J, Stemmermann GN, Nomura RY, Perez-Perez GI, Blaser MJ. Helicobacter pylori cagA seropositivity and gastric carcinoma risk in a Japanese American population. J Infect Dis 2002;186:1138-1144.
29. Wu AH, Crabtree JE, Bernstein L, Hawtin P, Cockburn M, Tseng CC, Forman D. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 2003;103:815-821.
30. Gurbuz AK, Ozel AM, Yazgan Y, Gunay A, Ozdemir S, Demirturk L, Emekdas G. Seropositivity against Helicobacter pylori CagA in Turkish gastric cancer patients. J Clin Gastroenterol 2001;33:389-392.
31. Figueroa G, Troncoso M, Toledo MS, Faundez G, Acuna R. Prevalence of serum antibodies to Helicobacter pylori VacA and CagA and gastric diseases in Chile. J Med Microbiol 2002;51:300-304.
32. Louw JA, Kidd MS, Kummer AF, Taylor K, Kotze U, Hanslo D. The relationship between Helicobacter pylori infection, the virulence genotypes of the infecting strain and gastric cancer in the African setting. Helicobacter 2001;6:268-273.
33. Enroth H, Kraaz W, Rohan T, Nyren O, Engstrand L. Does the method of Helicobacter pylori detection influence the association with gastric cancer risk? Scand J Gastroenterol 2002;37:884-890.
34. Brenner H, Arndt V, Bode G, Stegmaier C, Ziegler H, Stumer T. Risk of gastric cancer among smokers infected with Helicobacter pylori. Int J Cancer 2002;98:446-449.
35. Wong BCY, Chu KM, Lam SK, Kwok E, Lai KC, Hu WHC, Ching CK, Covacci A. CagA positive strains increase the risk of gastric cancer in Hong Kong with moderate prevalence of Helicobacter pylori infection and gastric cancer mortality (abstr). Gastroenterology 1998;114:G2914.
36. Kim TH, Chang DK, Lee CH, Jung HC, Song IS, Kim CY. Helicobacter pylori infection and risk of gastric cancer in Korea: correlation with atrophic gastritis and intestinal metaplasia (abstr). Gastroenterology 1998;114:G2567.
37. Konturek SJ, Starzynska T, Marlicz K, Konturek PC, Bielanski W, Rembiasz A, Ziemniak A, Hahn EG. Helicobacter pylori (HP), cagA status and plasma gastrin in the development of gastric cancer (abstr). Gut 2000;47(suppl I):A74.
38. Lawniczak MD, Konturek S, Karczewska E, Marlicz K, Starzynska T. Does H. pylori infection protect the host from cardia carcinoma (abstr)? Gut 2001;49(suppl III):2692.
39. Sorberg M, Engstrand L, Strom M, Jonsson KA, Jorbeck H, Granstrom M. The diagnostic value of enzyme immunoassay and immunoblot in monitoring eradication of Helicobacter pylori. Scand J Infect Dis 1997;29:147-151.
40. Klaamas K, Held M, Wadstrom T, Lipping A, Kurtenkov O. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer 1996;67:1-5.
41. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 1999;94:2373-2379.
42. Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 1999;13:851-856.
43. Hazell SL, Hennessy WB, Borody TJ, Carrick J, Ralston M, Brady L, Lee A. Campylobacter pyloridis gastritis II: distribution of bacteria and associated inflammation in the gastroduodenal environment. Am J Gastroenterol 1987;82:297-301.
44. Robey-Cafferty SS, Ro JY, Cleary KR. The prevalence of Campylobacter pylori in gastric biopsies from cancer patients. Mod Pathol 1989;2:473-476.
45. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on meta-analyses. BMJ 2000;320:1574-1577.